| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/08/2009 | US20090011497 Peptides and related compounds having thrombopoietic activity |
| 01/08/2009 | US20090011043 Tissue sealant made from whole blood |
| 01/08/2009 | US20090010934 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 01/08/2009 | US20090010916 C-1 Inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis |
| 01/08/2009 | CA2691638A1 Piperidine derivatives useful as orexin receptor antagonists |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | EP2011802A2 Anti-CD40 monoclonal antibody |
| 01/07/2009 | EP2011800A2 Inhibitors of caspase |
| 01/07/2009 | EP2010220A2 Stabilized pentosan polysulfate (pps) formulations and methods of analyzing them |
| 01/07/2009 | EP2010195A2 Fucoidans for reducing blood coagulation |
| 01/07/2009 | EP2010176A2 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 01/07/2009 | EP1592416B1 Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis |
| 01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
| 01/07/2009 | EP1357909B1 Il-8 receptor antagonists |
| 01/07/2009 | EP1204665B1 Chemokine receptor antagonists and methods of use therefor |
| 01/07/2009 | CN101341124A Six-membered heterocycles useful as serine protease inhibitors |
| 01/07/2009 | CN101340933A Factor xa inhibitor inclusion complex with cyclodextrin |
| 01/07/2009 | CN101340921A Extract for preventing and treating embolus disease |
| 01/07/2009 | CN101340906A Therapeutic agent or therapeutic method for ischemic stroke |
| 01/07/2009 | CN101337988A New erythrocyte-stimulating factor analogues |
| 01/07/2009 | CN101337985A Self-assembly short peptides constructed by D type amino acid, use for nano-biomedicine |
| 01/07/2009 | CN101337891A Nitric oxide donor type 3-butylphthalide derivates, method for preparing same and pharmaceutical use |
| 01/07/2009 | CN101337020A Traditional Chinese medicine composition for preventing frog gastroenteritis and hemorrhagic disease |
| 01/07/2009 | CN101336997A Medicine for hemorrhage after drug abortion |
| 01/07/2009 | CN101336947A Hemostasia powder for deer |
| 01/07/2009 | CN101336936A Compound thrombolytic and pericardium clearing complex capsule and preparation method thereof |
| 01/07/2009 | CN101336703A Blood-stasis cooling decoction |
| 01/07/2009 | CN101336673A Water ice formulation capable of arresting blood after tonsil operation |
| 01/07/2009 | CN101336671A Low-fat freezing beverage and preparation method thereof |
| 01/07/2009 | CN100448888C Haemostatically active preparation containing VWF and production thereof |
| 01/07/2009 | CN100448440C Protective solution for preventing local ischemic damage |
| 01/07/2009 | CN100448430C Oil-in-water type nanometer grassleaved sweetflag oil emulsion oral liquid and its prepn process |
| 01/06/2009 | US7473761 Therapy for metabolic disorders; polycystic kidney diseasel diarrhea; gastrointestinal disorders |
| 01/06/2009 | US7473686 Thrombopoietin mimetics |
| 01/06/2009 | CA2486697C 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 01/06/2009 | CA2421267C Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 01/06/2009 | CA2369504C Pyrazole compositions useful as inhibitors of erk |
| 01/06/2009 | CA2244512C Dietary supplements containing natural ingredients |
| 01/06/2009 | CA1341588C Human ifn-beta2/i1-6, its purification and use |
| 01/01/2009 | US20090005432 Pharmaceutical compositions including low dosages of desmopressin |
| 01/01/2009 | US20090005430 Receptor Blocker and Vasodilator Comprising Indole Derivative as Active Ingredient |
| 01/01/2009 | US20090005426 Pharmaceutically active sulfonyl hydrazide derivatives |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 01/01/2009 | US20090005310 (En) Pharmaceutical Composition for Treating Haemorrhagic Shock and its Consecutive Symptoms |
| 01/01/2009 | US20090005297 Aprotinin Variants |
| 01/01/2009 | US20090005292 Novel Peptides that Bind to the Erythropoietin Receptor |
| 01/01/2009 | US20090004738 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
| 01/01/2009 | US20090004265 Prevention and Treatment of Thromboembolic Disorders |
| 01/01/2009 | US20090004242 Coatings and Biomedical Implants Formed From Keratin Biomaterials |
| 01/01/2009 | US20090004240 Implants with a phosphazene-containing coating |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004163 Method of enhancing proliferation and/or hematopoietic differentiation of stem cells |
| 01/01/2009 | US20090004158 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 12/31/2008 | WO2009001968A1 Benzazepine derivatives useful as vasopressin antagonists |
| 12/31/2008 | WO2009001949A1 Pyrazolone derivative |
| 12/31/2008 | WO2009001915A1 Substituted imidazole compound and use thereof |
| 12/31/2008 | WO2009001743A1 Novel adamts-13 mutant |
| 12/31/2008 | WO2009001128A1 1,2-cycl0hexane dicarboxamides as cathepsin inhibitors |
| 12/31/2008 | WO2009000955A1 Microparticles of alginate modified with rgd as a release system for medicines |
| 12/31/2008 | WO2009000894A1 Anti-vpac1 antibodies and their uses |
| 12/31/2008 | WO2009000150A1 The use of sanchinoside in treating septicemia |
| 12/31/2008 | EP2009027A1 Anti-CD40 monoclonal antibody |
| 12/31/2008 | EP2009026A1 Anti-VPAC1 antibodies and their uses |
| 12/31/2008 | EP2007813A2 Agonist erythropoietin receptor antibodies |
| 12/31/2008 | EP2007812A2 Erythropoietin receptor agonists |
| 12/31/2008 | EP2007755A2 Fused ring thrombin receptor antagonists |
| 12/31/2008 | EP2007371A1 Lactate and calcium containing pharmaceutical composition and uses thereof |
| 12/31/2008 | EP1660536B1 FACTOR IXa SPECIFIC ANTIBODIES DISPLAYING FACTOR VIIIa LIKE ACTIVITY |
| 12/31/2008 | EP1437137B1 Drugs comprising combination of antithrombotic agent with pyrazolone derivative |
| 12/31/2008 | EP1364957B1 Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| 12/31/2008 | EP1272527B1 Preparation of antibodies having adcc via cd16, such as anti-rhesus d monoclonal antibodies |
| 12/31/2008 | EP0912730B1 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/31/2008 | CN101336111A Method for preparing a factor H concentrate and the use thereof in the form of a drug |
| 12/31/2008 | CN101333531A CXCR4 antagonist recombination protein SDF-1 beta P2G, preparation method and application thereof |
| 12/31/2008 | CN101333256A Human antibodies that bind human il-12 and methods for producing |
| 12/31/2008 | CN101333223A Method for preparing clopidogrel and salts thereof |
| 12/31/2008 | CN101333174A N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/31/2008 | CN101332277A Preparation method of emergency liquor for raising the whole blood |
| 12/31/2008 | CN101332243A Zigui jujube deer blood capsule capable of enriching blood and replenishing qi |
| 12/31/2008 | CN101332242A Decoction for treating hemorrhoidal hemorrhage |
| 12/31/2008 | CN101332222A Decoction for treating chronic bronchitis hemoptysis |
| 12/31/2008 | CN101332211A Leech extract and preparation method and use thereof |
| 12/31/2008 | CN101332182A Emulsion containing alprostadil for intravenous transfusion and preparation method thereof |
| 12/31/2008 | CN100447154C Use of HMG fragments as anti-inflammatory agents |
| 12/31/2008 | CN100447151C Peptide boronic acids useful in making salts thereof |
| 12/31/2008 | CN100447150C Isolation of lectins |
| 12/31/2008 | CN100446810C Non-neurotoxic plasminogen activating factors for treating stroke |
| 12/31/2008 | CN100446783C Method for preparing injection of astragalus |
| 12/31/2008 | CN100446779C Method for preparing acanthopanax senticousus extracting liquid/extraction |
| 12/31/2008 | CA2693226A1 New compounds with antithrombin function and pharmaceutical compositions on their basis |
| 12/31/2008 | CA2692363A1 New anticoagulant compounds, pharmaceutical compositions comprising these compounds for treatment of thrombotic states, and plasma-substituting solutions to correct hypercoagulation defects of hemodilution |
| 12/31/2008 | CA2690335A1 Benzazepine derivatives useful as vasopressin antagonists |
| 12/30/2008 | US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response |
| 12/30/2008 | US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance |
| 12/30/2008 | US7470687 Aryl oximes |
| 12/30/2008 | US7470678 Diphenylazetidinone derivatives for treating disorders of the lipid metabolism |
| 12/30/2008 | US7470671 Thioxylose compounds, preparation method thereof, pharmaceutical compositions containing same and use thereof in therapeutics |
| 12/30/2008 | CA2412560C Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 12/30/2008 | CA2351703C Novel 4-dedimethylaminotetracycline derivatives |